BIO-TECHNE CORP's ticker is TECH and the CUSIP is 09073M104. A total of 431 filers reported holding BIO-TECHNE CORP in Q4 2020. The put-call ratio across all filers is 1.11 and the average weighting 0.2%.
About BIO-TECHNE CORP
Bio-Techne Corp is a leading provider of innovative life science research tools and diagnostic solutions. The company is headquartered in Minneapolis, Minnesota, and has operations in over 50 countries worldwide. Bio-Techne's products and services are used by researchers and clinicians in a wide range of fields, including cancer research, stem cell research, and immunology.
Bio-Techne's success is due in large part to its commitment to innovation and customer service. The company invests heavily in research and development, and has a team of over 1,000 scientists working to develop new products and technologies. Bio-Techne also has a strong focus on customer service, with a dedicated team of technical support specialists available to assist customers with any questions or issues they may have.
In addition to its research tools and diagnostic solutions, Bio-Techne also has a growing portfolio of clinical diagnostic products. The company's Exosome Diagnostics subsidiary is a leader in the development of liquid biopsy tests for cancer diagnosis and monitoring.
Bio-Techne's leadership team is comprised of experienced executives with a track record of success in the life sciences industry. Charles Kummeth, the company's CEO, has been with Bio-Techne since 2013 and has overseen significant growth and expansion during his tenure.
Overall, Bio-Techne is a company with a strong reputation for innovation, customer service, and leadership in the life sciences industry. With a growing portfolio of products and services, the company is well-positioned for continued success in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,036,947 | -20.5% | 15,233 | -4.7% | 0.00% | -20.0% |
| Q2 2023 | $1,304,214 | +84975.9% | 15,977 | -22.7% | 0.01% | -28.6% |
| Q1 2023 | $1,533 | -9.3% | 20,664 | +1.3% | 0.01% | -12.5% |
| Q4 2022 | $1,690 | -99.9% | 20,403 | +296.1% | 0.01% | 0.0% |
| Q3 2022 | $1,462,000 | -52.2% | 5,151 | -41.7% | 0.01% | -50.0% |
| Q2 2022 | $3,061,000 | -21.1% | 8,831 | -1.4% | 0.02% | -15.8% |
| Q1 2022 | $3,878,000 | -32.2% | 8,957 | -18.9% | 0.02% | -29.6% |
| Q4 2021 | $5,717,000 | +21.1% | 11,051 | +13.4% | 0.03% | +8.0% |
| Q3 2021 | $4,720,000 | +1.2% | 9,742 | -6.0% | 0.02% | -3.8% |
| Q2 2021 | $4,666,000 | +26.6% | 10,365 | +7.4% | 0.03% | +4.0% |
| Q1 2021 | $3,685,000 | +20.4% | 9,649 | +0.1% | 0.02% | +8.7% |
| Q4 2020 | $3,061,000 | +56.0% | 9,642 | +21.7% | 0.02% | +27.8% |
| Q3 2020 | $1,962,000 | +14.3% | 7,921 | +21.9% | 0.02% | 0.0% |
| Q2 2020 | $1,717,000 | +58.8% | 6,499 | +14.0% | 0.02% | +28.6% |
| Q1 2020 | $1,081,000 | +584.2% | 5,702 | +693.0% | 0.01% | +600.0% |
| Q4 2019 | $158,000 | +10.5% | 719 | -1.2% | 0.00% | 0.0% |
| Q3 2019 | $143,000 | -10.6% | 728 | -5.0% | 0.00% | 0.0% |
| Q2 2019 | $160,000 | -24.9% | 766 | -28.7% | 0.00% | -33.3% |
| Q1 2019 | $213,000 | +99.1% | 1,075 | +44.9% | 0.00% | +50.0% |
| Q4 2018 | $107,000 | -29.1% | 742 | 0.0% | 0.00% | 0.0% |
| Q3 2018 | $151,000 | +37.3% | 742 | 0.0% | 0.00% | 0.0% |
| Q2 2018 | $110,000 | – | 742 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Broadcrest Asset Management, LLC | 275,000 | $18,719,250 | 20.14% |
| Montanaro Asset Management Ltd | 408,800 | $27,827,016 | 4.90% |
| Sandhill Capital Partners LLC | 613,061 | $41,731,091 | 3.90% |
| Pembroke Management, LTD | 365,611 | $24,887,141 | 3.40% |
| DF DENT & CO INC | 3,349,047 | $227,969,648 | 3.34% |
| Brown Capital Management | 3,158,004 | $214,965,332 | 3.30% |
| Ownership Capital B.V. | 1,786,273 | $121,591,603 | 3.05% |
| STONE RUN CAPITAL, LLC | 86,335 | $5,876,823 | 2.88% |
| Jackson Square Partners, LLC | 1,260,547 | $85,805,434 | 2.87% |
| Summit Creek Advisors LLC | 284,681 | $19,378,236 | 2.64% |